Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Paternership will likely happen after the COVID trials this summer yield positive results god willing
Me like!!!
VIRI LONG😎💰
https://t.co/ERcL1XY0V2 pic.twitter.com/XW8Grnboic
— Virios Therapeutics (@ViriosBiotech) April 2, 2024
VIRI LONG😎💰
https://t.co/ERcL1XY0V2 pic.twitter.com/XW8Grnboic
— Virios Therapeutics (@ViriosBiotech) April 2, 2024
I think it's going to kick into high gear again shortly.
I bit some more at.54
Somebody is soaking after hours. Nice buys! 58
It's waste like you that does nothing, contributes nothing and sits back and downplays everyone WINNER here. .30-.57 1 week. Read it and weep see you at 1.00
The pump is in full effect. Take profits
TEAM VIRI up 21% today!!😎💰
Interesting
Looks great for bloody day. 63 is key level. That's our big breakout
I can feel some heat already
We know what happens after the pumping. LOL
No miracle dude. This is about to catch fire again.
It's a miracle!
Holding up very nicely here
$VIRI
Those are long gone..just like last year when we ran from current levels to $2.45
Why? Wait for .30's
Greg is a horrible CEO. Think about why. Releasing little nothing bits of snooze, and they are still behind on enrollment. He's responsible for the languishing stock price and I bet he would pull the rug out on retail as before.
Great PR but I'm looking for something a little more meaty..I think we get it very soon..
Cheers
ATLANTA, March 26, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (NASDAQ:VIRI) (the "Company"), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia ("FM") and Long-COVID ("LC"), today announced that the World Intellectual Property Organization (WIPO) has published Virios' global patent application titled "Valacyclovir and Celecoxib for the Treatment of Alzheimer's and COVID-19", which covers the use of IMC-2, a proprietary combination of valacyclovir and celecoxib. This milestone enables Virios to streamline the process for obtaining patent protection globally, representing a precursor to the national phase of patent examination by targeted countries across the globe.
An open-label, exploratory LC study sponsored by Virios demonstrated that treatment with the combination of valacyclovir and celecoxib resulted in clinical and statistically significant reductions in LC associated fatigue, orthostatic intolerance, pain and anxiety. Combination treatment with valacyclovir and celecoxib is presently being assessed in a double blind, placebo-controlled study under the direction of Dr. Lucinda Bateman, MD, supported by an unrestricted, investigational grant provided by the Company to the Bateman Horne Center. Results from this important trial are expected this summer.
The 2024 National Center for Health Statistics Household Pulse Survey estimates that 17.6% of the US population have experienced LC, representing upwards of 45 million potential adult patients, since the pandemic started in November of 2019. Previous estimates suggest that up to 10 million children in the US have also experienced LC. There are no treatments approved by the FDA to treat the symptoms associated with LC, further highlighting the need for new treatments.
A multitude of studies suggest that while LC is a consequence of SARS-CoV-2 virus infection, the development of LC seems related to immune system dysfunction and complement activation. It has been postulated that an exhausted immune response to COVID-19 enables reactivation of previously dormant herpesviruses. Reactivated herpesviruses such as Epstein-Barr virus (EBV) may be associated with fatigue and cognitive dysfunction. Fatigue and cognitive dysfunction are predominant LC symptoms.
This acquisition would be a drop in the bucket for Pfizer😎 Show me the MONEY!!!!
And again
You can sprinkle your dust on me any time !!!
may the fairies be with us, and their magic dust
Sprinkled some green fairy dust..
Lfg
$VIRI
All I know is I got back in slightly lower than I got in before the run last year..
Wink
He was unloading this POS after he had loaded it. That's how it works.
VIRI...........................https://stockcharts.com/h-sc/ui?s=VIRI&p=W&b=5&g=0&id=p86431144783
come on cj. sprinkle some of your lucky dust and get this moving again
yep nice tweet frank playing it again
Followers
|
62
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4178
|
Created
|
06/09/21
|
Type
|
Free
|
Moderators DavidLeeRoth |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |